Stockreport

Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025

Galapagos NV - American Depositary Shares  (GLPG) 
Last galapagos nv - american depositary shares earnings: 10/24 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: glpg.com/company-overview
PDF High complete response rates and minimal residual disease (MRD) negativity, with durable responses, in high-risk mantle cell lymphoma (MCL) with GLPG5101, a fresh, early [Read more]